Doximity [DOCS] vs Ge Healthcare [GEHC] Detailed Stock Comparison

Doximity

Ge Healthcare
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Doximity wins in 7 metrics, Ge Healthcare wins in 12 metrics, with 0 ties. Ge Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Doximity | Ge Healthcare | Better |
---|---|---|---|
P/E Ratio (TTM) | 63.66 | 14.86 | Ge Healthcare |
Price-to-Book Ratio | 13.73 | 3.44 | Ge Healthcare |
Debt-to-Equity Ratio | 1.16 | 107.67 | Doximity |
PEG Ratio | 2.33 | 1.16 | Ge Healthcare |
EV/EBITDA | 54.29 | 11.05 | Ge Healthcare |
Profit Margin (TTM) | 39.88% | 11.22% | Doximity |
Operating Margin (TTM) | 37.48% | 14.62% | Doximity |
EBITDA Margin (TTM) | 37.48% | 14.62% | Doximity |
Return on Equity | 24.25% | 25.80% | Ge Healthcare |
Return on Assets (TTM) | 13.13% | 5.77% | Doximity |
Free Cash Flow (TTM) | $266.74M | $1.55B | Ge Healthcare |
Dividend Yield | N/A | 0.27% | N/A |
1-Year Return | 66.89% | -15.97% | Doximity |
Price-to-Sales Ratio (TTM) | 23.63 | 1.67 | Ge Healthcare |
Enterprise Value | $13.24B | $40.59B | Ge Healthcare |
EV/Revenue Ratio | 22.46 | 2.03 | Ge Healthcare |
Gross Profit Margin (TTM) | 89.18% | 39.65% | Doximity |
Revenue per Share (TTM) | $3 | $44 | Ge Healthcare |
Earnings per Share (Diluted) | $1.18 | $4.92 | Ge Healthcare |
Beta (Stock Volatility) | 1.37 | 1.28 | Ge Healthcare |
Doximity vs Ge Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Doximity | 1.91% | -3.21% | 7.45% | 21.38% | 24.23% | 34.41% |
Ge Healthcare | 1.73% | 7.44% | 7.29% | 0.92% | -3.20% | -1.99% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Doximity | 66.89% | 146.55% | 30.67% | 30.67% | 30.67% | 30.67% |
Ge Healthcare | -15.97% | 35.39% | 35.39% | 35.39% | 35.39% | 35.39% |
News Based Sentiment: Doximity vs Ge Healthcare
Doximity
News based Sentiment: MIXED
October brought a mix of positive financial projections and concerning signals for Doximity. While the company is expected to continue growing revenue and earnings, a downgrade from Goldman Sachs, significant insider selling, and potential regulatory risks create uncertainty. This combination of factors makes October a significant month for investors to reassess their positions.
Ge Healthcare
News based Sentiment: MIXED
October presented a mixed picture for GE HealthCare, with analyst downgrades balanced by upgrades and continued investment in innovation and partnerships. The upcoming Q3 earnings release on October 29th is a key event that will shape the investment narrative and provide clarity on the company's performance.
Performance & Financial Health Analysis: Doximity vs Ge Healthcare
Metric | DOCS | GEHC |
---|---|---|
Market Information | ||
Market Cap | $14.07B | $33.37B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 1,577,510 | 3,567,540 |
90 Day Avg. Volume | 1,326,787 | 3,275,250 |
Last Close | $71.99 | $76.82 |
52 Week Range | $40.87 - $85.21 | $57.65 - $94.80 |
% from 52W High | -15.51% | -18.97% |
All-Time High | $107.79 (Sep 06, 2021) | $94.80 (Feb 10, 2025) |
% from All-Time High | -33.21% | -18.97% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.15% | 0.04% |
Quarterly Earnings Growth | 0.29% | 0.14% |
Financial Health | ||
Profit Margin (TTM) | 0.40% | 0.11% |
Operating Margin (TTM) | 0.37% | 0.15% |
Return on Equity (TTM) | 0.24% | 0.26% |
Debt to Equity (MRQ) | 1.16 | 107.67 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $5.47 | $21.27 |
Cash per Share (MRQ) | $4.49 | $8.19 |
Operating Cash Flow (TTM) | $294.12M | $2.00B |
Levered Free Cash Flow (TTM) | $231.29M | $1.58B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 0.27% |
Last 12-Month Dividend | N/A | $0.19 |
Valuation & Enterprise Metrics Analysis: Doximity vs Ge Healthcare
Metric | DOCS | GEHC |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 63.66 | 14.86 |
Forward P/E | 63.13 | 15.65 |
PEG Ratio | 2.33 | 1.16 |
Price to Sales (TTM) | 23.63 | 1.67 |
Price to Book (MRQ) | 13.73 | 3.44 |
Market Capitalization | ||
Market Capitalization | $14.07B | $33.37B |
Enterprise Value | $13.24B | $40.59B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 22.46 | 2.03 |
Enterprise to EBITDA | 54.29 | 11.05 |
Risk & Other Metrics | ||
Beta | 1.37 | 1.28 |
Book Value per Share (MRQ) | $5.47 | $21.27 |
Financial Statements Comparison: Doximity vs Ge Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | DOCS | GEHC |
---|---|---|
Revenue/Sales | $145.91M | $4.78B |
Cost of Goods Sold | $15.79M | $2.77B |
Gross Profit | $130.12M | $2.01B |
Research & Development | $26.80M | $344.00M |
Operating Income (EBIT) | $54.52M | $628.00M |
EBITDA | $57.31M | $842.00M |
Pre-Tax Income | $64.15M | $692.00M |
Income Tax | $10.83M | $104.00M |
Net Income (Profit) | $53.32M | $588.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | DOCS | GEHC |
---|---|---|
Cash & Equivalents | $209.61M | $2.45B |
Total Current Assets | $1.09B | $9.74B |
Total Current Liabilities | $156.26M | $9.97B |
Long-Term Debt | $10.19M | $7.06B |
Total Shareholders Equity | $1.08B | $9.42B |
Retained Earnings | $186.89M | $3.81B |
Property, Plant & Equipment | $8.89M | $369.00M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | DOCS | GEHC |
---|---|---|
Operating Cash Flow | $119.90M | $509.00M |
Capital Expenditures | $0 | $-152.00M |
Free Cash Flow | $96.98M | $98.00M |
Debt Repayment | N/A | $-257.00M |
Common Stock Repurchase | $-26.79M | N/A |
Short Interest & Institutional Ownership Analysis
Metric | DOCS | GEHC |
---|---|---|
Shares Short | 4.82M | 7.46M |
Short Ratio | 3.93 | 2.39 |
Short % of Float | 0.04% | 0.02% |
Average Daily Volume (10 Day) | 1,577,510 | 3,567,540 |
Average Daily Volume (90 Day) | 1,326,787 | 3,275,250 |
Shares Outstanding | 188.88M | 456.96M |
Float Shares | 133.22M | 455.23M |
% Held by Insiders | 0.02% | 0.00% |
% Held by Institutions | 0.91% | 0.88% |
Dividend Analysis & Yield Comparison: Doximity vs Ge Healthcare
Metric | DOCS | GEHC |
---|---|---|
Last 12-Month Dividend | N/A | $0.19 |
Last 12-Month Dividend Yield | N/A | 0.27% |
3-Year Avg Annual Dividend | N/A | $0.12 |
3-Year Avg Dividend Yield | N/A | 0.04% |
3-Year Total Dividends | N/A | $0.37 |
Ex-Dividend Date | N/A | Oct 24, 2025 |